Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?

Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Speci...

Descrición completa

Gardado en:

Detalles Bibliográficos
Formato:	Online
Idioma:	inglés
Publicado:	MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:	adverse events lower-urinary-tract dysfunction therapeutic efficacy urinary incontinence voiding dysfunction botulinum toxin A onabotulinum toxin A bladder pain syndrome/interstitial cystitis long-term treatment bladder pain syndrome interstitial cystitis Sapylin liposome bladder oversensitivity detrusor overactivity interstitial cystitis/bladder pain syndrome botulinum toxin A injection urine biomarkers bladder inflammation botulinum toxin urethral detrusor underactivity urethral sphincter dysfunction dysfunctional voiding poor relaxation of the external sphincter botulinum toxins type A urinary bladder overactive aged postoperative complications spinal cord injury neurogenic bladder onabotulinumtoxinA botox platelet-rich plasma intravesical injection incontinence Parkinson’s disease stroke dyssynergia overactive bladder men lower urinary tract symptoms n/a thema EDItEUR::M Medicine and Nursing
Acceso en liña:	ONIX_20230714_9783036579382_79
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?

Títulos similares: Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?

Títulos similares